The estimated Net Worth of Kenneth P Iii Fallon is at least $693 Mille dollars as of 10 May 2021. Mr. Fallon owns over 20,000 units of Conformis stock worth over $576,079 and over the last 9 years he sold CFMS stock worth over $116,800. In addition, he makes $0 as Independent Chairman of the Board at Conformis.
Kenneth has made over 5 trades of the Conformis stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 20,000 units of CFMS stock worth $18,400 on 10 May 2021.
The largest trade he's ever made was selling 80,000 units of Conformis stock on 26 April 2018 worth over $116,800. On average, Kenneth trades about 15,769 units every 146 days since 2016. As of 10 May 2021 he still owns at least 254,902 units of Conformis stock.
You can see the complete history of Mr. Fallon stock trades at the bottom of the page.
Kenneth P. Fallon III serves as Independent Chairman of the Board of the Company. Mr. Fallon retired from active employment in March 2003. From time to time between March 2004 to June 2009, Mr. Fallon served as an advisor to Kairos Partners, an investment firm. Mr. Fallon retired as the chairman of the board of Axya Medical, Inc., a medical device company, in March 2003. Prior to that, Mr. Fallon also served as the chief executive officer of Axya Medical, Inc.; as president of the surgical business at Haemonetics Corporation, a manufacturer of blood processing technology; as chief executive officer and chairman of the board of UltraCision, Inc., a developer and manufacturer of ultrasonically powered surgical instruments; as president and chief executive officer of American Surgical Technologies Corporation, a company that manufactures laparoscopic viewing systems; as president, U.S. operations of Zimmer, Inc., a joint replacement company and then a subsidiary of Bristol-Myers Squibb Company; as president of Zimmer’s Orthopaedic Implant Division and as its vice president of marketing and positions of significant responsibility with the Codman and Orthopaedic Divisions of Johnson & Johnson, a global healthcare company. Mr. Fallon also served as a member of the board of directors of Osteotech, Inc., a company that produces bone graft materials for spinal procedures, from 1995 to 2010, including serving as chairman from April 2005 to August 2010, until it was acquired by Medtronic, Inc. Mr. Fallon has a B.B.A. degree in marketing from the University of Massachusetts and an M.B.A. from Northeastern University.
Kenneth Fallon is 80, he's been the Independent Chairman of the Board of Conformis since 2016. There are no older and 14 younger executives at Conformis.
Kenneth's mailing address filed with the SEC is C/O CONFORMIS, INC., 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.
Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang e Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: